Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts

Blood

Volumn 98, Issue 2, 2001, Pages 398-404

  Nielsen, Susanne D ^a,b,c,d   Jeppesen, Dorthe L ^a,b,c,d   Kolte, Lilian ^a,b,c,d   Clark, Dawn R ^a,b,c,d   Sørensen, Tine U ^a,b,c,d   Dreves, Anne Mette ^a,b,c,d   Ersbøll, Annette K ^a,b,c,d   Ryder, Lars P ^a,b,c,d   Valerius, Niels H ^a,b,c,d   Nielsen, Jens O ^a,b,c,d  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; STAVUDINE; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADULT; ARTICLE; CELL FUNCTION; CHILD; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; LYMPHOCYTE CLONE; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PREGNANCY COMPLICATION; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE SUBPOPULATION;

EID: 0035880253     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.2.398     Document Type: Article

References (50)

1. Burns DN, Mofenson LM. Pediatric HIV-1 infection. Lancet. 1999;354(suppl 2):1-6.
2. Kind C, Rudin C, Siegrist CA, et al. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. AIDS. 1998;12:205-210.
3. Aldhous MC, Watret KC, Mok JYQ, Bird AG, Froebel KS. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol. 1994;97:61-67.
4. Froebel KS, Doherty KV, Whitelaw JA, Hague RA, Mok JY, Bird AG. Increased expression of the CD45RO (memory) antigen on T cells in HIV-infected children. AIDS. 1991;5:97-99.
5. + lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1997;4:358-361.
6. Roques PA, Gras G, Parnet-Mathieu F, et al. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS. 1995;9:F19-F26.
7. Rowland-Jones SL, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet. 1993;341:860-861.
8. Clerici M, Saresalla M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000;96:3866-3871.
9. Clark DR, Ampel NM, Hallett CA, Yedavalli VRK, Ahmad N, De Luca D. Peripheral blood from human immunodeficiency virus type 1-infected patients displays diminished T cell generation capacity. J Infect Dis. 1997;176:649-654.
10. Clark DR, Repping S, Pakker NG, et al. T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. Blood. 2000;96:242-249.
11. Nielsen SD, Ersbøll AK, Mathiesen L, Nielsen JO, Hansen JES. Highly active antiretroviral therapy (HAART) normalizes the function of progenitor cells in human immunodeficiency virus (HIV)-infected patients. J Infect Dis. 1998;178:1299-1305.
12. De Luca A, Teofili L, Antinori A, et al. Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol. 1993;85:20-24.
13. Gill V, Shattock RJ, Scopes J, et al. Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: nonreversal by nucleoside analogues. J Infect Dis. 1997;176:1510-1516.
14. Re MC, Zauli G, Gibellini D, et al. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS. 1993;7:1049-1055.
15. Sloand EM, Young NS, Sato T, et al. Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS. 1997;11:1547-1553.
16. Steinberg HN, Crumpacker CS, Chatis PA. In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol. 1991;65:1765-1769.
17. Zauli G, Re MC, Furlini G, Giovannini M, La Placa M. Human immundeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic proenitors (CD34+ cells). J Gen Virol. 1992;73:417-421.
18. +) cells in AIDS patients. J Infect Dis. 1992;166:710-716.
19. Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:107-114.
20. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virussero-positive individuals. J Clin Invest. 1993;91:759-765.
21. Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 1997;11:1111-1118.
22. Richman DD, Fiscl MA, Grieco MH, et al. The toxcity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1987;317:192-197.
23. Prince HE, Lapé-Nixon M. CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type-1 infected patients. Clin Diagn Lab Immunol. 1997;4:217-222.
24. Nielsen SD, Afzelius P, Ersbøll AK, Nielsen JO, Hansen JES. Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients. Clin Exp Immunol. 1998;114:66-72.
25. Nielsen SD, Clark DR, Hutchings M, et al. Treatment with granulocyte-colony stimulating factor (G-CSF) decreases the capacity of hematopoietic progenitor cells for generation of lymphocytes in human immunodeficiency virus (HIV)-infected persons. J Infect Dis. 1999;180:1819-1826.
26. Nielsen SD, Husemoen LNN, Sørensen TU, Gram GJ, Hansen JES. FLT3 ligand preserves the uncommitted CD34+ CD38- progenitor cells during cytokine prestimulation for retroviral transduction. J Hematother Stem Cell Res. 2000;9:695-702.
27. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1998;16:1215.
28. McFarland RD, Douek DC, Koup RA, Picker LJ. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci U S A. 2000;97:4215-4220.
29. Lisse IM, Aaby P, Whittle H, Jensen H, Engelmann M, Christensen LB. T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr. 1997;130:77-85.
30. Plaeger-Marshall S, Hultin P, Bertolli J, et al. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children. J Acquir Immune Defic Syndr. 1993;6:984-993.
31. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood. 1993;82:2585-2594.
32. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609-4616.
33. Roederer M, Raju PA, Mitra DK, Herzenberg LA, Herzenberg LA. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J Clin Invest. 1997;99:1555-1564.
34. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature. 1990;348:163-166.
35. Michie CA, McLean A, Alcock C, Beverley PCL. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 1992;360:264-265.
36. Douek DC, McFarland RD, Kelser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695.
37. Economides A, Schmid I, Anisman-Posner DJ, Plaeger S, Bryson YJ, Uittenbogaart CH. Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol. 1998;5:230-234.
38. Hazenberg MD, Otto SA, Stuart JWTC, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042.
39. Douek DC, Koup RA, McFarland RD, Sullivan JL, Luzuriaga K. Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis. 2000;181:1479-1482.
40. Vigano A, Vella S, Saresella M, et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS. 2000;14:251-261.
41. Gaulton GN, Scobie JV, Rosenzweig M. HIV and the thymus. AIDS. 1997;1:403-414.
42. Papiernik M, Brossad Y, Mulliez N, et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics. 1992;89:297-301.
43. Miles S, Balden E, Magpantay L, et al. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N Engl J Med. 1993;328:297-302.
44. Sugiura K, Oyaizu N, Pahwa R, Kalyanaraman VS, Pahwa S. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood. 1992;80:1463-1469.
45. Than S, Oyaizu N, Pahwa RN, Kalyanaraman VS, Pahwa S. Effect of human immunodeficiency virus type-1 envelope glycoprotein gp160 on cytokine production from cord-blood T cells. Blood. 1994;84:184-188.
46. Shah MM, Li Y, Christensen RD. Effects of perinatal zidovudine on hematopoiesis: a comparison of effects on progenitors from human fetuses versus mothers. AIDS. 1996;10:1239-1247.
47. Foudraine NA, de Jong JJ, Jan Weverling G, et al. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine. AIDS. 1998;12:1513-1519.
48. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin in American blacks. Arch Intern Med. 1991;151:501-505.
49. Cavazzana-Calvo M, Hacein-Bey S, Basile GS, et al. Gene therapy of severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288:669-672.
50. Li X, Gervaix A, Kang D, et al. Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies. Gene Ther. 1998;5:233-239.